Bull Of The Day: High Tide
High Tide (HITI) is a Zacks Rank #2 (Buy) that has an A for Value and an A for Growth. The company is in the marijuana space and there is a lot of talk about marijuana being rescheduled in order to …
Innocan Pharma Showcases Non-Opioid Pain Solution at PAINWeek 2025
Innocan Pharma Corporation is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the company has developed a CBD-loaded liposome drug delivery platform for …
CENTR Brands Corp. Extends Debenture Maturity Amid Strategic Shifts
CENTR Brands ( ($TSE:CNTR) ) just unveiled an update. CENTR Brands Corp. has amended the terms of a previously issued unsecured convertible …
Alabama CBD stores navigate new hemp product bans as President Trump eyes marijuana reclassification
Changes to federal and state regulations regarding marijuana, THC, and Delta 8 are proving challenging for some local CBD stores in Alabama, as new laws ban certain hemp products.
CV Sciences Sales Down 10 Percent
Operating income turned positive, mostly due to a $0.5 million one-time benefit, with actual operating income of $11,000, but adjusted EBITDA remains negative. These 10 stocks could mint the next wave …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Sydney to see eight new office projects until Q4 2027
These will yield nearly 200,000sqm of stock. There were three office completions in Sydney totalling 46,900 sqm over the second quarter and no withdrawals in the CBD, according to a JLL report. There …
Innocan Pharma’s CBD Technology Gains Traction at PAINWeek Conference
InnoCan Pharma ( ($TSE:INNO) ) has provided an update. Innocan Pharma’s presentation on its Liposomal Synthetic CBD Technology at the PAINWeek …
Elixinol Wellness to Quote 46.8 Million Securities on ASX
An announcement from Elixinol Wellness ( ($AU:EXL) ) is now available. Elixinol Wellness Limited has announced the quotation of 46,800,000 …
MediaX Agency Unveils Linkible — The AI-Powered Link Building Agency for Law Firms, SaaS, Cannabis & CBD, iGaming, Casino, and E-commerce
MediaX Agency Unveils Linkible — The AI-Powered Link Building Agency for Law Firms, SaaS, Cannabis & CBD, iGaming, Casino, and E-commerce …
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ / ACCESS Newswire / August 5, 2025 / CBD Life Sciences Inc. (OTC:CBDL …
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of …
Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.
Flora Growth Corp. (FLGC) Leaps Into Web3 With $1M Crypto Bet
Flora Growth Corp. (NASDAQ:FLGC) is among the cheap pot stocks to buy. It is a global cannabis company headquartered in Fort Lauderdale, Florida, operating in over 15 countries. It offers a wide range …
Artelo Biosciences stock surges after receiving favorable UK regulatory guidance
Investing.com — Artelo Biosciences (NASDAQ: ARTL) stock surged 18% after the company received favorable guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for a Phase 1 …
INVESCO Ltd. stock underperforms Wednesday when compared to competitors
Shares of INVESCO Ltd. IVZ slid 1.10% to $21.48 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.12% to 6,362.90 and Dow …
Recent Comments